CERS1 and acute myeloid leukemia: Molecular or pharmacological targeting of FLT3-ITD reactivates CerS1/C18-ceramide generation, accompanied by mitochondrial division, mitophagy and cell death both in AML cell lines and blasts obtained from FLT3-ITD1 patients, and in xenograft models in vivo [249].